Search

everythinglearnresearchcommunity

for

Search:↓

Female pattern hair loss is common in women with polycystic ovarian syndrome.

Benign conditions can mimic serious ones in postmenopausal hyperandrogenism, requiring careful diagnosis.

Removing the ovarian tumor improved the woman's hormonal symptoms.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

A genetic defect causes males in some Mediterranean populations to be born with ambiguous genitalia and develop male traits at puberty.

All women with significant unwanted hair growth have hormonal imbalances, often from polycystic ovary syndrome.

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

A woman had a rare liver tumor causing male-like physical changes, highlighting the need for thorough checks when such symptoms appear.

Hormone therapy increases facial and body hair in transgender men, while hair removal improves well-being in transgender women, but cost is a barrier as insurance often doesn't cover it. Dermatologists can use various treatments for these hair issues.

Early diagnosis and treatment are crucial for complex medical conditions.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Estrogen alone may effectively suppress testosterone in some transfeminine individuals.

After menopause, some women lose scalp hair and gain facial hair, with patterns suggesting different underlying causes.

Erythromelanosis follicularis faciei can also affect women, though it's rare.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

African-American girls tend to start puberty earlier than white girls, possibly due to increased androgen production.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

Hormonal imbalances can cause acne, excess hair growth, and hair loss in women, needing combined medical and emotional care.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Men with hormonal imbalances similar to PCOS may have increased risk of metabolic and heart diseases.

High levels of male hormones in pregnant mice cause heart enlargement and poor heart function in their female babies.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

Excessive androgen in women can cause acne, hair growth, baldness, and PCOS, often treatable with medication.

A patient with Werner syndrome showed a range of aging-like symptoms and metabolic issues, underscoring the need for early detection and treatment.

Five new mutations in the androgen receptor gene were found, helping to understand androgen insensitivity syndrome better.

An mFG score of 7 or higher indicates hirsutism in Filipino women, often linked to higher free testosterone levels.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.